SAVE Moms and Babies Act of 2026
Senate Bill Would Ban Mail-Order Abortion Pills and Block New Abortion Drug Approvals
Legislative Progress
Key Points
- This bill would stop the government from approving any new drugs used to end a pregnancy. It also halts any ongoing medical research or clinical trials aimed at developing new abortion medications, requiring those studies to shut down within three years.
- For abortion pills that are already legal, the bill adds strict new rules. It would ban these pills from being sent through the mail or picked up at a regular pharmacy, requiring patients to receive them in person from a doctor at a clinic, medical office, or hospital.
- Doctors who prescribe these drugs would have to be specially certified. They would need to prove they can accurately check how far along a pregnancy is, perform surgery if there are complications like heavy bleeding, and ensure the patient has access to a hospital for blood transfusions if needed.
- The policy would limit the use of these drugs to the first 70 days (10 weeks) of pregnancy. It also requires doctors and drug companies to report all serious health problems, infections, or hospitalizations related to the medication to the FDA.
Impact Analysis
Personal Impact
Life & Work
This bill would dramatically restrict access to medication abortion (mifepristone), which is currently used in more than half of all abortions in the U.S. Patients would no longer be able to receive abortion pills by mail or from a pharmacy — they'd have to go to a clinic, medical office, or hospital to get the pills in person from a specially certified doctor. This creates significant new barriers, especially for people in rural areas or states with few abortion providers, and eliminates telehealth-based medication abortion entirely.
Programs
Disabilities
Milestones
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S292)
Sent to a congressional committee for expert review. The committee decides whether this bill moves forward.
Introduced in Senate
The bill was officially filed and given a number. It now enters the legislative queue.
Votes
No votes have been recorded for this legislation yet.
Related News
3 articles
Hyde-Smith Bill Targets Medication Abortions with 'SAVE Moms and Babies Act'
Senator Cindy Hyde-Smith reintroduced the SAVE Moms and Babies Act to roll back FDA policies that expanded access to chemical abortion drugs. The bill would restore in-person dispensing requirements, ban mail-order distribution, and prevent the approval of new abortion medications.
Hyde-Smith pushes to restore safety standards for chemical abortion drugs
The SAVE Moms and Babies Act would require abortion drugs to be dispensed in person by a medical professional and ban distribution through the mail or via telemedicine. It also aims to prevent the FDA from approving new abortion drugs and strengthen reporting for complications.
Hyde-Smith introduces the SAVE Moms and Babies ACT
The Support and Value Expectant (SAVE) Moms and Babies Act would prevent labeling changes for already-approved abortion drugs and stop the FDA from approving new chemical abortion drugs. It mandates in-person medical oversight to protect women from the risks of 'do-it-yourself' abortions.
Source Information
Document Type
Congressional Bill
Official Title
SAVE Moms and Babies Act of 2026
Data Sources
Sponsor
Cosponsors
(31)Analysis generated by AI. Always verify with official sources.